Sinotherapeutics, Inc. Class ASSE: 688247

"SINOTHERAPEUTICS INC."Announcement on Voluntary Disclosure of Approval of Posaconazole Enteric-coated Tablets via the EU Decentralised Procedure (DCP)

Jul 25, 2026 · Issued by Sinotherapeutics, Inc. Class A via Shanghai Stock Exchange

Announcement on Voluntary Disclosure of Approval of Posaconazole Enteric-coated Tablets via the EU Decentralised Procedure (DCP)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Sinotherapeutics, Inc. Class A

"SINOTHERAPEUTICS INC."Announcement on Voluntary Disclosure of Doxofylline Tablets Passing the Consistency Evaluation of Generic Drugs and the Addition of a New SpecificationJul 14
"SINOTHERAPEUTICS INC."Announcement on Abnormal Fluctuations in Stock TradingJul 3
Announcement on Implementation of Dividend Distribution for 2025Jun 22
Announcement on the Expiry of Planned Time for Shareholders with Over 5% Shares to Reduce Shares and Results of Shareholding ReductionJun 11

All Sinotherapeutics, Inc. Class A news releases